Velogenic newcastle disease virus as an oncolytic virotherapeutics: in vitro characterization
/in International Publications, Newcastle Disease Virus /von 2012-05-29 / Appl. Biochem. Biotechnol. 2012 Aug;167(7):2005-22Construction of recombinant Newcastle disease virus Italien strain for oncolytic virotherapy of tumors
/in International Publications, Newcastle Disease Virus /von 2012-04-18 / Hum. Gene Ther. 2012 Jul;23(7):700-10Newcastle disease virus triggers autophagy in U251 glioma cells to enhance virus replication
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2012-03-08 / Arch. Virol. 2012 Jun;157(6):1011-8Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions
/in International Publications, Newcastle Disease Virus /von 2012-03-01 / Future Microbiol 2012 Mar;7(3):347-67Virotherapy of neuroendocrine tumors
/in International Publications, Newcastle Disease Virus /von 2012-02-29 / Neuroendocrinology 2013;97(1):26-34Targeting pediatric cancer stem cells with oncolytic virotherapy
/in International Publications, Newcastle Disease Virus /von 2012-02-15 / Pediatr. Res. 2012 Apr;71(4 Pt 2):500-10Newcastle disease virus LaSota strain kills human pancreatic cancer cells in vitro with high selectivity
/in International Publications, Newcastle Disease Virus, Pancreatic Cancer /von 2012-01-10 / JOP 2012 Jan;13(1):45-53Analysis of three properties of Newcastle disease virus for fighting cancer: tumor-selective replication, antitumor cytotoxicity, and immunostimulation
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2012-01-01 / Methods Mol. Biol. 2012;797:177-204Anti-leukemic activity of Newcastle disease virus strains AF2240 and V4-UPM in murine myelomonocytic leukemia in vivo
/in Acute Leukemia, International Publications, Newcastle Disease Virus /von 2011-11-30 / Leuk. Res. 2012 May;36(5):634-45
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de